14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026
CPSH vs FRSX: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
As of Nov 16, 2026, CPS Technologies Corp. (CPSH) is the stronger overall head-to-head candidate over Foresight Autonomous Holdings Ltd. (FRSX) in the Tradestie Institutional Equity Comparison Engine, winning 8–2 core matrix metrics and 6–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). CPSH carries a Unified Composite Score of 26.4/100 (SELL) at $3.67 (67.7x Forward P/E, -1.6% operating margin), whereas FRSX carries 47.2/100 (HOLD) at $0.55 (N/M Forward P/E, -2642.2% operating margin).
Composite vs. Pillar Nuance: While FRSX currently prints a higher short-term Unified Composite Score (47.2/100 HOLD vs. CPSH 26.4/100 SELL), CPSH captures the overall institutional head-to-head verdict (8–2 matrix metrics and 6–0 across the 6 pillars) due to superior fundamental profitability (-1.6% vs. -2642.2% operating margin) and revenue trajectory (+1.1% vs. -32.8% YoY).
Technical & Structure Timing Caution: CPSH is currently in a Weinstein Distribution regime near a flattening 50-day moving average and Breakdown options structure phase (RSI 46.6); meanwhile FRSX is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 20.8). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on CPSH vs FRSX. Trailing 12-month operating profitability (CPSH -1.6% vs FRSX -2642.2%) and valuation multiples (CPSH 67.7x vs FRSX N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Competes within the Auto Parts value chain with $2.3M market capitalization and -2642.2% operating margin.
OpEx & R&D ReinvestmentN/A
90D Engineering Disclosures0 Published
Investor FAQ CPSH vs FRSX Key Questions & Quantitative Answers
As of Nov 16, 2026, CPS Technologies Corp. (CPSH) is the stronger overall head-to-head candidate over Foresight Autonomous Holdings Ltd. (FRSX) in the Tradestie Institutional Equity Comparison Engine, winning 8–2 core matrix metrics and 6–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). CPSH carries a Unified Composite Score of 26.4/100 (SELL) at $3.67 (67.7x Forward P/E, -1.6% operating margin), whereas FRSX carries 47.2/100 (HOLD) at $0.55 (N/M Forward P/E, -2642.2% operating margin). Composite vs. Pillar Nuance: While FRSX currently prints a higher short-term Unified Composite Score (47.2/100 HOLD vs. CPSH 26.4/100 SELL), CPSH captures the overall institutional head-to-head verdict (8–2 matrix metrics and 6–0 across the 6 pillars) due to superior fundamental profitability (-1.6% vs. -2642.2% operating margin) and revenue trajectory (+1.1% vs. -32.8% YoY). Technical & Structure Timing Caution: CPSH is currently in a Weinstein Distribution regime near a flattening 50-day moving average and Breakdown options structure phase (RSI 46.6); meanwhile FRSX is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 20.8). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
CPSH leads the Growth & Scale pillar: CPSH posts +1.1% YoY revenue growth and +78.6% YoY earnings growth on $32M TTM revenue (15.1% gross margin, -1.6% operating margin), compared with FRSX at -32.8% YoY revenue growth and +0.0% YoY earnings growth on $445,000 TTM revenue (65.4% gross margin, -2642.2% operating margin). On trailing 12-month operating scale, CPSH generates $32M in USD-normalized revenue versus $445,000 for FRSX. In operating R&D and SG&A reinvestment, CPSH deploys 16.7% of Rev ($5.4M) (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for FRSX.
CPSH screens cheaper on headline valuation multiples. CPSH trades at 67.7x Forward P/E, 70.9x Trailing P/E, N/M PEG, and 2.6x EV/Revenue (-12.2% FCF margin), whereas FRSX trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and 5.2x EV/Revenue (unreported EBITDA margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against CPSH (0.4% ROE) versus FRSX (-205.9% ROE) capital efficiency.
In options market volatility and institutional positioning, CPSH carries 160.7% implied volatility (62nd %ile, Elevated (60th–80th %ile)), a 0.69x (Call-Skewed) Put/Call open-interest ratio, NEUTRAL on-balance volume, and sits in a BREAKDOWN options structure phase (3.08β · 83% Vol realized risk). By comparison, FRSX carries N/A implied volatility (N/A, Unclassified), thin ADR options open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (1.14β · 53% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.